TY  - RPRT
TI  - Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by sequential intermittent anti-PI3Ka/b/δ and anti-PD-1 treatment
AU  - Qi, Z.
AU  - Hong, W.
AU  - Xu, Z.
AU  - zhang, l.
AU  - Zou, Y.
AU  - Yan, W.
AU  - Li, C.
AU  - Liu, N.
PY  - 2020
DO  - 10.1101/2020.10.17.343608
UR  - https://www.biorxiv.org/content/10.1101/2020.10.17.343608v1
ID  - 10.1101/2020.10.17.343608
ER  -